Status:
TERMINATED
Do Patients With Skin Psoriasis Have Sub-clinical Features of Active Psoriatic Arthritis on Musculoskeletal UltraSound?
Lead Sponsor:
The Royal Wolverhampton Hospitals NHS Trust
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Psoriatic Arthritis is an inflammatory condition that typically affects joints and soft tissues such as tendons. Poorly controlled or untreated psoriatic arthritis can lead to joint damage, disability...
Eligibility Criteria
Inclusion
- Diagnosis of Psoriasis by a dermatologist
- Aged 18 or more
- Reasonable fluency of spoken English
Exclusion
- Existing diagnosis of Psoriatic arthritis
- Currently on biologics for treatment of their skin Psoriasis (as this would potentially treat and thereby diminish joint symptoms associated with PsA)
- Aged \<18years old (the study focusses on an adult population)
- Currently in prison (would be unable to attend the study ultrasound scan)
- Unable to give written consent for a musculoskeletal ultrasound e.g. advanced dementia, learning difficulties (may be unable to appreciate the reason for the study and may be unable to tolerate sitting relatively still for an ultrasound scan for 60 minutes)
Key Trial Info
Start Date :
June 22 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 30 2021
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04857476
Start Date
June 22 2021
End Date
July 30 2021
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
George Hirsch
Wolverhampton, United Kingdom, WV10 0QP